LOS ANGELES AREA, Calif., Dec. 14, 2015 (GLOBE NEWSWIRE) -- Beazley Group (BEZ.L), a leading insurer of healthcare professional liability and miscellaneous medical risks, today announced the addition of Sarah Fiorito to its growing miscellaneous medical healthcare team. She will be based in Beazley's Los Angeles office.
Ms Fiorito joins Beazley from Kinsale Insurance, where she was a life sciences underwriter. At Beazley, she will focus on nutraceutical risks. In April, Beazley launched NutraGuard, a policy customized for nutraceutical manufacturers and distributors with the flexibility to cover products liability, general liability, errors and omissions (E &O), product recall expenses, employee benefits liability, cyber/privacy, and hired/non-owned auto insurance.
John Livatino, miscellaneous medical underwriter and the designer of NutraGuard, said: "We are seeing strong growth in our miscellaneous medical business as brokers and clients discover the benefits of carefully tailored coverage to address the varied and complex exposures they confront. NutraGuard is a great example of the flexible coverage we can offer and I am delighted that Sarah will be joining our team to expand our underwriting capabilities in this field."
Beazley's miscellaneous medical team offers various combinations of medical professional liability, general liability, products liability and errors & omissions coverages, on both a primary and excess basis. Clients include healthcare staffing agencies, home health services, behavioral health services, clinical trial sponsors, tissue/blood banks, nutraceutical companies, organ procurement organizations, contract research organizations, correctional healthcare providers, medi-spas, occupational health services, dialysis clinics, and ground/air ambulances.
The miscellaneous medical team underwrites six of the top ten clinical research organizations and four of the largest healthcare staffing organizations in the US.
CONTACT: Sean Carroll
1-770-390-1563
[email protected]


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



